Niu, F.-W., Zhang, Y.-J., Li, K. and Zhang, M.-S. (2014) “Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways”, Bangladesh Journal of Pharmacology, 9(3), pp. 406–412. doi: 10.3329/bjp.v9i3.19567.